These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26254217)

  • 1. A mathematical model for lymphangiogenesis in normal and diabetic wounds.
    Bianchi A; Painter KJ; Sherratt JA
    J Theor Biol; 2015 Oct; 383():61-86. PubMed ID: 26254217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-temporal Models of Lymphangiogenesis in Wound Healing.
    Bianchi A; Painter KJ; Sherratt JA
    Bull Math Biol; 2016 Sep; 78(9):1904-1941. PubMed ID: 27670430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.
    Maruyama K; Asai J; Ii M; Thorne T; Losordo DW; D'Amore PA
    Am J Pathol; 2007 Apr; 170(4):1178-91. PubMed ID: 17392158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mRNA expressions and immunohistochemistry of factors involved in angiogenesis and lymphangiogenesis in the early stage of rat skin incision wounds.
    Kameyama H; Udagawa O; Hoshi T; Toukairin Y; Arai T; Nogami M
    Leg Med (Tokyo); 2015 Jul; 17(4):255-60. PubMed ID: 25794881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice.
    Kurashige C; Hosono K; Matsuda H; Tsujikawa K; Okamoto H; Majima M
    FASEB J; 2014 Mar; 28(3):1237-47. PubMed ID: 24308973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenic growth factors, receptors and therapies.
    Lohela M; Saaristo A; Veikkola T; Alitalo K
    Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
    Hong YK; Lange-Asschenfeldt B; Velasco P; Hirakawa S; Kunstfeld R; Brown LF; Bohlen P; Senger DR; Detmar M
    FASEB J; 2004 Jul; 18(10):1111-3. PubMed ID: 15132990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
    Ji RC; Miura M; Qu P; Kato S
    Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.
    Asai J; Takenaka H; Hirakawa S; Sakabe J; Hagura A; Kishimoto S; Maruyama K; Kajiya K; Kinoshita S; Tokura Y; Katoh N
    Am J Pathol; 2012 Dec; 181(6):2217-24. PubMed ID: 23138019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
    Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric VEGF-ENZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization.
    Zheng Y; Watanabe M; Kuraishi T; Hattori S; Kai C; Shibuya M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):503-11. PubMed ID: 17194893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage dynamics in diabetic wound dealing.
    Waugh HV; Sherratt JA
    Bull Math Biol; 2006 Jan; 68(1):197-207. PubMed ID: 16794927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.
    Koch M; Dettori D; Van Nuffelen A; Souffreau J; Marconcini L; Wallays G; Moons L; Bruyère F; Oliviero S; Noel A; Foidart JM; Carmeliet P; Dewerchin M
    J Pathol; 2009 Nov; 219(3):356-64. PubMed ID: 19718705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Jeon BH; Jang C; Han J; Kataru RP; Piao L; Jung K; Cha HJ; Schwendener RA; Jang KY; Kim KS; Alitalo K; Koh GY
    Cancer Res; 2008 Feb; 68(4):1100-9. PubMed ID: 18281485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of Lymphangiogenesis by Targeted Delivery of VEGF-C Improves Diabetic Wound Healing.
    Brunner LM; He Y; Cousin N; Scholl J; Albin LK; Schmucki B; Supersaxo S; Restivo G; Hafner J; Neri D; Werner S; Detmar M
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why and how do tumors stimulate lymphangiogenesis?
    Cao Y
    Lymphat Res Biol; 2008; 6(3-4):145-8. PubMed ID: 19093786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the effects of treating diabetic wounds with engineered skin substitutes.
    Waugh HV; Sherratt JA
    Wound Repair Regen; 2007; 15(4):556-65. PubMed ID: 17650100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.